Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether BMS-936559 is safe and has the desired pharmacologic activity in patients who have severe sepsis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07300306 · Sepsis, Septic Shock, and more
NCT07550400 · Septic Shock, Fluid Resuscitation
NCT07230041 · Septic Shock
NCT07367113 · Sepsis, Septic Shock, and more
NCT04955210 · Critical Illness, Severe Sepsis
Uc Davis Medical Center
Sacramento, California
Local Institution
Denver, Colorado
University Of Florida
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions